Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2015
Development and validation of a melanoma risk score based on pooled data from 16 case-control studiesJohn R Davies, Yu-mei Chang, D Timothy Bishop, et al.
Clinical Genitourinary Cancer|December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
Nature Cancer|February 5, 2022
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsetsNina Bhardwaj, Philip A Friedlander, Anna C Pavlick, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Pigment Cell & Melanoma Research|July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL studyLi Luo, Ronglai Shen, Arshi Arora, et al.
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III MelanomaJennifer M Wiggins, Qiao Zhang, Yian Zhang, et al.
Plos One|April 3, 2023
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanomaIrene Orlow, Keimya D Sadeghi, Sharon N Edmiston, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.
Pageof 17